
Telmibet Trio 40mg/5mg/12.5mg Tablet
Marketer
Shamac Health Care Pvt Ltd
Salt Composition
Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Telmibet Trio 40mg/5mg/12.5mg Tablet
Triomix HT 40mg/5mg/12.5mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, mitigating the risk of stroke and heart attack. Triomix HT can be taken with or without food; dosage is individualized based on response and condition. Consistent daily timing is recommended. Continue treatment as directed by your physician. As it includes a diuretic, increased urination is expected; avoid dosing within four hours of bedtime. Regular use, even feeling well, is crucial for optimal benefit. Hypertension often presents asymptomatically; cessation increases cardiovascular event risk. Common side effects may include headache, dizziness, lethargy, altered taste, fatigue, influenza-like symptoms, diarrhea, and sinus inflammation. Report persistent, worsening, or bothersome side effects to your doctor. Adequate hydration is vital to counteract potential side effects like muscle weakness, dry mouth, or thirst. Prior to commencing treatment, inform your physician of any kidney or liver conditions, pregnancy, breastfeeding, or concurrent medications, particularly those for hypertension or cardiac issues. Regular monitoring of blood pressure, renal function, electrolyte levels, and blood glucose is essential to ensure treatment efficacy.
Primary Ingredients of Telmibet Trio 40mg/5mg/12.5mg Tablet
The provided text is "undefined," which lacks meaning and cannot be rephrased. No rewrite is possible.
Uses of Telmibet Trio 40mg/5mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Telmibet Trio 40mg/5mg/12.5mg Tablet:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the Telmibet Trio 40mg/5mg/12.5mg Tablet whole; avoid chewing, crushing, or fracturing. Consumption may coincide with meals or be taken independently; however, consistent timing is recommended.
Common Side effects of Telmibet Trio 40mg/5mg/12.5mg Tablet:
- Dizziness
- Nausea
- Peripheral edema
- Flu-like symptoms
- Diarrhea
- Upper respiratory tract infection
- Visual disturbance
How to use Telmibet Trio 40mg/5mg/12.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Telmibet Trio 40mg/5mg/12.5mg Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. This medication can be administered with or without food, however, consistent timing is recommended.
How Telmibet Trio 40mg/5mg/12.5mg Tablet works:
Telmisartan, Amlodipine, and Hydrochlorothiazide (40mg/5mg/12.5mg) are combined in Telmibet Trio tablets to manage hypertension. This formulation uses an angiotensin receptor blocker (Telmisartan), a calcium channel blocker (Amlodipine), and a diuretic (Hydrochlorothiazide). Amlodipine and Telmisartan lower blood pressure by promoting vasodilation, while Hydrochlorothiazide reduces blood pressure by increasing urination and, over time, contributing to vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telmibet Trio 40mg/5mg/12.5mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Telmibet Trio 40mg/5mg/12.5mg tablets during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingUNSAFE
Use of Telmibet Trio 40mg/5mg/12.5mg tablets is contraindicated while breastfeeding due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.
DrivingUNSAFE
Driving ability may be impaired by side effects of Telmibet Trio 40mg/5mg/12.5mg Tablets. These side effects can include dizziness, headaches, nausea, or fatigue, potentially impacting concentration and driving safety.
KidneyCAUTION
Individuals with severe kidney impairment should use Telmibet Trio 40mg/5mg/12.5mg tablets cautiously. Dosage modification may be necessary; physician consultation is advised. Telmibet Trio 40mg/5mg/12.5mg tablets are generally unsuitable for patients exhibiting severe renal dysfunction.
LiverCAUTION
Patients with liver impairment should exercise caution when using Telmibet Trio 40mg/5mg/12.5mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Telmibet Trio 40mg/5mg/12.5mg Tablet :
Should you forget a Telmibet Trio 40mg/5mg/12.5mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telmibet Trio 40mg/5mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |
